Patients who have already undergone an angiography or bypass surgery can also take this treatment to improve their angina pain and avoid future surgeries. This is because unlike bypass surgery and angioplasty, EECP targets entire heart altogether and improves overall heart circulation.
Enhanced external counterpulsation (EECP) treatment is an FDA-approved outpatient therapy for chronic stable angina. It uses pressure on the lower limbs to improve blood flow in people with long-term symptoms of heart disease, such as chest pain and pressure.
EECP therapy uses pressure to improve your blood flow. It's a noninvasive, outpatient treatment. You typically receive the treatment over seven weeks.
This type of therapy can reduce your need for medication and increase your ability to be active without experiencing symptoms. Side effects are usually minor. Your healthcare provider can help determine if you are eligible for EECP treatment.